Skip to main content

nl
fr
en
de

Other official information and services: www.belgium.be

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Home
Human medicines
Veterinary medicines
Information for the public
Information for professionals

Home
Veterinary medicines
Particular products
Specially reglemented substances
GMO
Clinical trials

Medicines
- Medicines
Particular products
Health products
- Distribution

Clinical trials

Under construction.

Last updated on 01/01/2009

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

26/03/2020

Extension of the survey on the use of benzodiazepines and similar in the context of sleep disorders in Belgium

26/03/2020

Coronavirus: ban on the sale of rapid diagnostic tests due to the risk of misinterpretation

26/03/2020

Coronavirus: Belgian guideline for the management of clinical trials during the coronavirus pandemic

24/03/2020

PRAC March 2020 – Suspension of ulipristal acetate, review of liver injury risk –Testing and treatment recommendations for fluorouracil, capecitabine, tegafur and flucytosine – Review of ifosfamide cancer medicines

All news

© 2016 - FAMHP

Site map
Disclaimer